November 30, 2017 / 9:50 AM / 16 days ago

BRIEF-CytoTools Submission Of European Clinical Trials For Dermapro Imminent​

Nov 30 (Reuters) - CYTOTOOLS AG:

* ‍SUBMISSION OF EUROPEAN CLINICAL TRIALS FOR WOUND HEALING ACTIVE SUBSTANCE DERMAPRO(R) IMMINENT​

* ‍NEW AMERICAN INVESTOR, YORKVILLE ADVISORS GLOBAL, LP, PROVIDES A LONG-TERM FINANCING COMMITMENT​

* EUROPEAN CLINICAL TRIALS FOR WOUND HEALING SUBSTANCE DERMAPRO WILL START IN COMING WEEKS​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below